AR007983A1 - Formulacion - Google Patents
FormulacionInfo
- Publication number
- AR007983A1 AR007983A1 ARP970103327A ARP970103327A AR007983A1 AR 007983 A1 AR007983 A1 AR 007983A1 AR P970103327 A ARP970103327 A AR P970103327A AR P970103327 A ARP970103327 A AR P970103327A AR 007983 A1 AR007983 A1 AR 007983A1
- Authority
- AR
- Argentina
- Prior art keywords
- alpha
- drug
- formulation
- methoxyimino
- azabicyclo
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
El uso de [R-(Z)]-alfa-(metoxiimino)-alfa-(1-azabiciclo[2.2.2]acetonitrilo, o una sal farmacéuticamente aceptable del mismo en la preparación de unmedicamento para el tratamiento y/o profilaxis de la demencia en seres humanos, en el que elm edicamento está adaptado para ser aplicado a a la piel.Además describe una composición farmacéutica que comprende dichos compuestos y el método para prepararla.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9615628.6A GB9615628D0 (en) | 1996-07-25 | 1996-07-25 | Formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR007983A1 true AR007983A1 (es) | 1999-11-24 |
Family
ID=10797487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970103327A AR007983A1 (es) | 1996-07-25 | 1997-07-23 | Formulacion |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0918521B1 (es) |
| JP (1) | JP2000515868A (es) |
| KR (1) | KR20000029523A (es) |
| CN (1) | CN1226163A (es) |
| AR (1) | AR007983A1 (es) |
| AT (1) | ATE224711T1 (es) |
| BR (1) | BR9710546A (es) |
| CA (1) | CA2261233A1 (es) |
| CO (1) | CO5031290A1 (es) |
| CZ (1) | CZ22799A3 (es) |
| DE (1) | DE69715878T2 (es) |
| DK (1) | DK0918521T3 (es) |
| ES (1) | ES2184121T3 (es) |
| GB (1) | GB9615628D0 (es) |
| HK (1) | HK1021314A1 (es) |
| IL (1) | IL128095A (es) |
| NO (1) | NO990283L (es) |
| NZ (1) | NZ333704A (es) |
| PL (1) | PL331283A1 (es) |
| PT (1) | PT918521E (es) |
| TR (1) | TR199900141T2 (es) |
| TW (1) | TW426514B (es) |
| WO (1) | WO1998004258A1 (es) |
| ZA (1) | ZA976592B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9815383D0 (en) * | 1998-07-15 | 1998-09-16 | Smithkline Beecham Plc | Novel method of treatment |
| US6835850B2 (en) * | 2000-09-27 | 2004-12-28 | Dsw Ip Assets B.V. | Process for the carbonylation of a conjugated diene |
| GB0428170D0 (en) * | 2004-12-23 | 2005-01-26 | Biopartners Ltd | Mono and Combination Therapy |
| SG11202005962YA (en) | 2017-12-29 | 2020-07-29 | Guangzhou Maxinovel Pharmaceuticals Co Ltd | Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceutical composition, and application |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0392803B1 (en) * | 1989-04-13 | 2004-06-16 | Beecham Group p.l.c. | Novel compounds |
| MX9300875A (es) * | 1992-02-20 | 1993-08-31 | Smithkline Beecham Plc | Procedimiento para la preparacion de compuestos azabiciclicos. |
| GB9409705D0 (en) * | 1994-05-14 | 1994-07-06 | Smithkline Beecham Plc | Novel compounds |
| DE19501022C1 (de) * | 1995-01-14 | 1996-06-05 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung |
-
1996
- 1996-07-25 GB GBGB9615628.6A patent/GB9615628D0/en active Pending
-
1997
- 1997-07-14 CA CA002261233A patent/CA2261233A1/en not_active Abandoned
- 1997-07-14 BR BR9710546A patent/BR9710546A/pt unknown
- 1997-07-14 IL IL12809597A patent/IL128095A/en not_active IP Right Cessation
- 1997-07-14 DE DE69715878T patent/DE69715878T2/de not_active Expired - Fee Related
- 1997-07-14 WO PCT/EP1997/003872 patent/WO1998004258A1/en not_active Application Discontinuation
- 1997-07-14 KR KR1019997000576A patent/KR20000029523A/ko not_active Application Discontinuation
- 1997-07-14 CZ CZ99227A patent/CZ22799A3/cs unknown
- 1997-07-14 ES ES97934492T patent/ES2184121T3/es not_active Expired - Lifetime
- 1997-07-14 DK DK97934492T patent/DK0918521T3/da active
- 1997-07-14 PL PL97331283A patent/PL331283A1/xx unknown
- 1997-07-14 CN CN97196687A patent/CN1226163A/zh active Pending
- 1997-07-14 TR TR1999/00141T patent/TR199900141T2/xx unknown
- 1997-07-14 EP EP97934492A patent/EP0918521B1/en not_active Expired - Lifetime
- 1997-07-14 JP JP10508451A patent/JP2000515868A/ja active Pending
- 1997-07-14 NZ NZ333704A patent/NZ333704A/en unknown
- 1997-07-14 AT AT97934492T patent/ATE224711T1/de not_active IP Right Cessation
- 1997-07-14 PT PT97934492T patent/PT918521E/pt unknown
- 1997-07-23 AR ARP970103327A patent/AR007983A1/es unknown
- 1997-07-24 TW TW086110515A patent/TW426514B/zh not_active IP Right Cessation
- 1997-07-24 ZA ZA976592A patent/ZA976592B/xx unknown
- 1997-07-25 CO CO97042583A patent/CO5031290A1/es unknown
-
1999
- 1999-01-22 NO NO990283A patent/NO990283L/no unknown
- 1999-12-01 HK HK99105593A patent/HK1021314A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| TR199900141T2 (xx) | 1999-03-22 |
| GB9615628D0 (en) | 1996-09-04 |
| TW426514B (en) | 2001-03-21 |
| DE69715878T2 (de) | 2003-05-22 |
| CO5031290A1 (es) | 2001-04-27 |
| CA2261233A1 (en) | 1998-02-05 |
| PT918521E (pt) | 2003-02-28 |
| ZA976592B (en) | 1999-03-04 |
| WO1998004258A1 (en) | 1998-02-05 |
| BR9710546A (pt) | 1999-08-17 |
| NZ333704A (en) | 2000-06-23 |
| ATE224711T1 (de) | 2002-10-15 |
| HK1021314A1 (en) | 2000-06-09 |
| AU721101B2 (en) | 2000-06-22 |
| IL128095A0 (en) | 1999-11-30 |
| KR20000029523A (ko) | 2000-05-25 |
| NO990283L (no) | 1999-03-19 |
| CZ22799A3 (cs) | 1999-06-16 |
| DE69715878D1 (de) | 2002-10-31 |
| DK0918521T3 (da) | 2003-02-03 |
| CN1226163A (zh) | 1999-08-18 |
| NO990283D0 (no) | 1999-01-22 |
| EP0918521B1 (en) | 2002-09-25 |
| PL331283A1 (en) | 1999-07-05 |
| EP0918521A1 (en) | 1999-06-02 |
| JP2000515868A (ja) | 2000-11-28 |
| AU3768497A (en) | 1998-02-20 |
| IL128095A (en) | 2002-07-25 |
| ES2184121T3 (es) | 2003-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR019261A1 (es) | Cetoazalido de la clase de lactamas de 15 miembros, su uso, procedimiento para prepararlo , y una composicion farmaceutica util para el tratamiento de infecciones bacterianas en seres humanos y animales | |
| MX9200728A (es) | Formulacion farmaceutica adaptada para administracformulacion farmaceutica adaptada para administracion topica, para desordenes en la piel. ion topica, para desordenes en la piel. | |
| IL146133A0 (en) | Preparations for the application of anti-inflammatory agents | |
| ES2177024T3 (es) | Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer. | |
| HUP9802897A3 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
| AR007983A1 (es) | Formulacion | |
| AR011437A1 (es) | Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento. | |
| HK1012242A1 (en) | Topical composition containing penciclovir | |
| DE59205998D1 (de) | Arzneimittel mit antineoplastischer Wirkung enthaltend als Wirkstoff Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphat und Verfahren zu dessen Herstellung | |
| ES2101311T3 (es) | Utilizacion de un dispositivo transdermico que contiene (e)-2-(p-fluorofenetil)-3-fluoroalilamina y su uso para el tratamiento de la enfermedad de alzheimer. | |
| IL111138A (en) | Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia | |
| AU3429393A (en) | Pharmaceutical pentapeptide compositions and methods of use thereof | |
| HU9802896D0 (en) | Optically active piperidinoalkyl-4h-1,2,4-oxadiazine derivative, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
| MX9200555A (es) | Composicion farmaceutica para la aplicacion topicaterapeutica en el tratamiento de catarata pre-senil y senil. | |
| IT1246195B (it) | Composizioni farmaceutiche contenenti antibiotici aminoglicosidici atte alla somministrazione topica | |
| ES2062752T3 (es) | Preparado de una sal de oxipurinol en forma oral para el tratamiento de hiperuricemia. | |
| RU95119823A (ru) | Применение диэтиламинной соли церулетида для лечения псориаза | |
| IL105296A0 (en) | Pharmaceutical formulation for topical application in the treatment of dry skin | |
| IT1264428B1 (it) | Composizioni farmaceutiche per il trattamento della psoriasi | |
| IT1270958B (it) | Composizioni farmaceutiche a base di nimesulide, somministrabili per via orale, non gastrolesive e/o a rilascio controllato | |
| DE59405654D1 (de) | T-lymphozyten enthaltende pharmazeutische zusammensetzung zur behandlung von infektionen | |
| IT1267664B1 (it) | Composizione a base di fosfocreatina e suo uso farmaceutico | |
| IT1247936B (it) | Composizioni farmaceutiche per il trattamento di dermatosi | |
| ITMI911930A1 (it) | Composizioni farmaceutiche di stereoisomeri di ossiracetam e loro impiego terapeutico. | |
| KR930703003A (ko) | 피부질환치료용 제약 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |